Back to search

Article

RUNX1-deficiency drives immune-active ER <sup>+</sup> mammary tumorigenesis through activation of interferon signaling

2026-04-09

Abstract excerpt

<h4> Abstract </h4> Recurrent loss-of-function mutations in RUNX1 occur in estrogen receptor-positive (ER + ) breast cancers, yet how RUNX1-loss contributes to breast tumorigenesis remains unclear. Here we used genetically engineered mouse models with luminal mammary epithelial cell (MEC)-restricted gene disruption to investigate its role in breast cancer initiation. Loss of RUNX1 alone, or together with RB1,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f184417a-f529-554a-ae88-aaf1bc25312f
DOI
10.64898/2026.04.06.716728
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
RUNX1-deficiency drives immune-active ER <sup>+</sup> mammary tumorigenesis through activation of interferon signalingDOI 10.64898/2026.04.06.716728
Select a neighboring publication to make it the new centre.